Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
Dec 2022	42	Global Markets Direct	ASDR-613968

Published: Dec 2022 - Pages : 42 - Publisher : Global Markets Direct - Report code : ASDR-613968

Addex Therapeutics Ltd
Appello Pharmaceuticals Inc
Bio-Pharm Solutions Co Ltd
Bristol-Myers Squibb Co
Domain Therapeutics SA
H. Lundbeck AS